Autoimmune thrombocytopenia after six cycles of fludarabine phosphate in a patient with chronic lymphocytic leukemia.
Hematol Cell Ther
; 39(4): 209-12, 1997 Aug.
Article
de En
| MEDLINE
| ID: mdl-9352330
ABSTRACT
Fludarabine phosphate (FDR) has demonstrated a remarkable clinical activity in chronic lymphocytic leukemia (CLL). Myelosuppression is the main toxicity although autoimmune hemolytic anemia (AIHA) is frequently reported. The pathogenesis of AIHA is still unknown however the role of T-cell immunosuppression is suspected. One case of thrombopenia after FDR has been described in a patient with a previous history of an autoimmune thrombocytopenia. We here report a 73-year-old man with a B-CLL and no previous autoimmune disorder who received six courses of fludarabine phosphate and developed afterwards an autoimmune thrombocytopenia.
Recherche sur Google
Collection:
01-internacional
Base de données:
MEDLINE
Sujet principal:
Arabinofuranosyladénine monophosphate
/
Maladies auto-immunes
/
Thrombopénie
/
Leucémie chronique lymphocytaire à cellules B
/
Immunosuppresseurs
Limites:
Aged
/
Humans
/
Male
Langue:
En
Journal:
Hematol Cell Ther
Sujet du journal:
HEMATOLOGIA
Année:
1997
Type de document:
Article
Pays d'affiliation:
France